The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123796443 12379644 3 F 20150202 20160728 20160518 20160804 EXP JP-ROCHE-1759153 ROCHE 71.88 YR M Y 0.00000 20160804 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123796443 12379644 1 PS Rituximab RITUXIMAB 1 Intravenous (not otherwise specified) 103705 200 MG SOLUTION FOR INFUSION
123796443 12379644 2 SS GANCICLOVIR. GANCICLOVIR 1 Intravenous (not otherwise specified) 19661 500 MG
123796443 12379644 3 SS NEORAL CYCLOSPORINE 1 Oral 0 400 MG
123796443 12379644 4 SS NEORAL CYCLOSPORINE 1 Oral 0 250 MG
123796443 12379644 5 SS NEORAL CYCLOSPORINE 1 Oral 0 150 MG
123796443 12379644 6 SS PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral 25-40 MG 0
123796443 12379644 7 C SOLU-MEDROL METHYLPREDNISOLONE SODIUM SUCCINATE 1 Intravenous (not otherwise specified) 4 TO 20 MG 0
123796443 12379644 8 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 0
123796443 12379644 9 C SODIUM SUCCINATE SODIUM SUCCINATE HEXAHYDRATE 1 0
123796443 12379644 10 C REBAMIPIDE REBAMIPIDE 1 Oral 0 300 MG TABLET
123796443 12379644 11 C LASIX FUROSEMIDE 1 Oral 0 40 MG
123796443 12379644 12 C BAYASPIRIN ASPIRIN 1 Oral 0 100 MG
123796443 12379644 13 C POLARAMIN DEXCHLORPHENIRAMINE MALEATE 1 Intravenous (not otherwise specified) 0 5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123796443 12379644 1 Nephrotic syndrome
123796443 12379644 2 Infection
123796443 12379644 3 Nephrotic syndrome
123796443 12379644 6 Nephrotic syndrome
123796443 12379644 7 Nephrotic syndrome
123796443 12379644 10 Prophylaxis
123796443 12379644 11 Oedema
123796443 12379644 12 Prophylaxis
123796443 12379644 13 Premedication

Outcome of event

Event ID CASEID OUTC COD
123796443 12379644 HO
123796443 12379644 DE
123796443 12379644 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123796443 12379644 Blood pressure decreased
123796443 12379644 Disseminated intravascular coagulation
123796443 12379644 Hepatic function abnormal
123796443 12379644 Leukopenia
123796443 12379644 Nephrotic syndrome
123796443 12379644 Pneumonia
123796443 12379644 Sepsis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123796443 12379644 1 20150121 20150121 0
123796443 12379644 2 20150217 20150225 0
123796443 12379644 3 20141227 20150206 0
123796443 12379644 4 20150105 20150109 0
123796443 12379644 5 20150110 20150206 0
123796443 12379644 6 20141216 20150206 0
123796443 12379644 7 20150207 20150301 0
123796443 12379644 10 20141216 20150104 0
123796443 12379644 11 20141228 20150206 0
123796443 12379644 12 20141226 20150105 0
123796443 12379644 13 20150121 20150121 0